Illumina competitors

Illumina's competitors include Synthetic Genomics, Vical, Nightstar Therapeutics and Intellia Therapeutics
Add company...
Illumina
Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.
Synthetic Genomics
Synthetic Genomics is a synthetic biology company that develops and commercializes genomic-driven technologies for various industries.
Vical
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.
Nightstar Therapeutics
Nightstar Therapeutics is a clinical-stage gene therapy company, focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases.
Intellia Therapeutics
Intellia is developing therapeutic products to help people with genetic diseases.
Founding Date
Founding Date
1998
Founding Date
2005
Founding Date
1987
Founding Date
2013
Founding Date
2014
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Scoresby, AU
São Paulo, BR
Victoria, CA
Shanghai, CN
Beijing, CN
Minato, JP
see more
Locations
La Jolla, US HQ
Locations
San Diego, US HQ
Locations
London, GB HQ
Lexington, US
Locations
Cambridge, US HQ
Employees
Employees
6,20013% increase
Employees
205
Employees
73
Employees
2323% decrease
Employees
10470% increase
Valuation ($)
Valuation ($)
42.7 b
Valuation ($)
N/A
Valuation ($)
26.4 m
Valuation ($)
461.8 m
Valuation ($)
1.2 b
Facebook likes
Facebook likes
15.4 k
Facebook likes
3.7 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Twitter followers
Twitter followers
57 k
Twitter followers
2.8 k
Twitter followers
65
Twitter followers
115
Twitter followers
2.2 k

Financial

Revenue (est.)
Revenue (est.)
$2.4b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$13.8m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
$428.1m (FY, 2017)
Net income
N/A
Net income
($13m) (FY, 2017)
Net income
($12.2m) (FY, 2016)
Net income
($10.6b) (FY, 2016)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 40m
Total funding raised
N/A
Total funding raised
$ 99.6m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Synthetic Genomics
HQ
La Jolla, US
Employees
205

Synthetic Genomics is a synthetic biology company that develops and commercializes genomic-driven technologies for various industries.

View company
Vical
HQ
San Diego, US
Employees
73

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.

View company
Nightstar Therapeutics
HQ
London, GB
Employees
23↓ 23% decrease

Nightstar Therapeutics is a clinical-stage gene therapy company, focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases.

View company
Intellia Therapeutics
HQ
Cambridge, US
Employees
104

Intellia is developing therapeutic products to help people with genetic diseases.

View company